Share Price and Basic Stock Data
Last Updated: January 17, 2026, 8:46 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bombay Oxygen Investments Ltd operates as a non-banking financial company (NBFC) and has exhibited fluctuating revenue trends over the past quarters. The company recorded sales of ₹17.45 Cr in September 2022, which subsequently declined to ₹7.13 Cr in December 2022, before experiencing a significant downturn to -₹6.47 Cr in March 2023. The revenue rebounded to ₹21.80 Cr in June 2023, highlighting volatility in operational performance. However, subsequent quarters showed a mix of positive and negative sales, with September 2023 recording ₹14.07 Cr and December 2023 at ₹22.32 Cr. This erratic pattern continued into 2024, with projected sales of ₹12.66 Cr in March 2024 and rising to ₹29.01 Cr in June 2024. The trailing twelve months (TTM) sales stood at -₹9.57 Cr, indicating ongoing challenges in sustaining revenue growth. Given the company’s market capitalization of ₹310 Cr and a current share price of ₹20,700, the revenue trends suggest a need for strategic adjustments to stabilize and enhance sales consistency.
Profitability and Efficiency Metrics
Profitability metrics for Bombay Oxygen Investments reveal significant challenges, particularly highlighted by a reported net profit of -₹8.77 Cr. The operating profit margin (OPM) for the company has shown remarkable efficiency, standing at 95.33% for the financial year ending March 2025. However, the overall profitability remains compromised, as evidenced by the net profit margins that have fluctuated dramatically, with a peak of 86.60% in March 2025 but significant losses in prior periods. The return on equity (ROE) was recorded at 3.62%, indicating limited returns for shareholders, while the return on capital employed (ROCE) stood at 3.89%. The cash conversion cycle (CCC) is notably low at 8 days, suggesting that the company efficiently manages its receivables and payables. Nonetheless, the erratic sales and the negative net profit underscore the need for operational improvements to translate high margins into sustainable profitability.
Balance Sheet Strength and Financial Ratios
Bombay Oxygen Investments boasts a robust balance sheet, characterized by zero borrowings, indicating a strong capital structure without reliance on debt financing. The reserves of ₹513.07 Cr reflect a solid cushion against operational volatility and provide the company with financial flexibility. The price-to-book value (P/BV) ratio is at a low 0.68x, suggesting that the stock may be undervalued compared to its book value, which stands at ₹32,204.87 per share. The current ratio is exceptionally high at 2464.27, indicating an abundance of current assets relative to current liabilities, a sign of liquidity strength. However, the asset turnover ratio remains low at 0.04%, indicating inefficiencies in generating revenue from assets. The company’s enterprise value (EV) is ₹331.29 Cr, reflecting its market valuation relative to its operating income. Overall, while the balance sheet appears strong, operational inefficiencies may hinder overall financial performance.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bombay Oxygen Investments indicates a strong promoter holding of 73.29%, which has remained stable across multiple reporting periods. This substantial stake suggests a high level of confidence from the promoters in the company’s long-term prospects. Institutional investment remains minimal, with foreign institutional investors (FIIs) being absent and domestic institutional investors (DIIs) holding just 0.06%. The public shareholding stands at 26.66%, with the number of shareholders rising to 3,039 as of September 2025, reflecting a modest increase in retail investor participation. The low institutional interest could be a point of concern, as it may indicate a lack of broader market confidence in the company’s future performance. However, the stable promoter holding could provide a sense of security for existing investors, indicating a commitment to the company’s growth trajectory.
Outlook, Risks, and Final Insight
Looking ahead, Bombay Oxygen Investments faces both opportunities and challenges. The company’s strong balance sheet, marked by zero debt and substantial reserves, positions it well to navigate market fluctuations. However, the erratic revenue patterns and negative net profit indicate that operational strategies must be refined to achieve consistent profitability. Risks include potential market volatility and the company’s reliance on a narrow revenue base, which has proven unstable. Additionally, the lack of institutional investment raises concerns about the company’s perceived value in the broader market context. To improve investor sentiment, management may need to articulate a clear strategy focused on revenue stability and growth. In scenarios of improved operational efficiency and successful new revenue initiatives, the company could enhance its profitability and attract institutional interest, potentially leading to a more favorable market valuation.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 13.6 Cr. | 1.36 | 1.91/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 7.23 Cr. | 0.72 | 7.55/0.62 | 21.3 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 403 Cr. | 61.5 | 125/53.9 | 40.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 15.2 Cr. | 16.5 | 26.2/15.0 | 12.5 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 32.8 Cr. | 73.0 | 152/66.1 | 17.6 | 238 | 1.37 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 28,813.00 Cr | 401.23 | 52.41 | 515.00 | 0.23% | 15.81% | 8.84% | 8.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.45 | 7.13 | -6.47 | 21.80 | 14.07 | 22.32 | 12.66 | 29.01 | 23.97 | -18.54 | -14.22 | 28.89 | -5.70 |
| Expenses | 0.42 | 0.42 | 0.43 | 0.41 | 0.39 | 0.40 | 0.62 | 0.42 | 0.39 | 0.38 | 0.45 | 0.40 | 0.42 |
| Operating Profit | 17.03 | 6.71 | -6.90 | 21.39 | 13.68 | 21.92 | 12.04 | 28.59 | 23.58 | -18.92 | -14.67 | 28.49 | -6.12 |
| OPM % | 97.59% | 94.11% | 98.12% | 97.23% | 98.21% | 95.10% | 98.55% | 98.37% | 98.62% | ||||
| Other Income | 0.05 | -0.00 | 4.22 | -0.00 | -0.00 | 0.01 | 1.37 | -0.00 | -0.00 | 0.69 | -0.00 | -0.00 | -0.00 |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Depreciation | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 |
| Profit before tax | 17.04 | 6.66 | -2.73 | 21.34 | 13.63 | 21.88 | 13.36 | 28.54 | 23.53 | -18.27 | -14.72 | 28.44 | -6.17 |
| Tax % | 10.33% | 9.76% | -21.25% | 8.29% | 12.99% | 20.16% | 34.96% | 5.96% | 21.59% | -15.33% | -16.44% | 14.84% | -15.24% |
| Net Profit | 15.28 | 6.02 | -2.16 | 19.57 | 11.86 | 17.47 | 8.69 | 26.84 | 18.45 | -15.48 | -12.30 | 24.23 | -5.22 |
| EPS in Rs | 1,018.67 | 401.33 | -144.00 | 1,304.67 | 790.67 | 1,164.67 | 579.33 | 1,789.33 | 1,230.00 | -1,032.00 | -820.00 | 1,615.33 | -348.00 |
Last Updated: January 9, 2026, 5:47 am
Below is a detailed analysis of the quarterly data for Bombay Oxygen Investments Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is -5.70 Cr.. The value appears to be declining and may need further review. It has decreased from 28.89 Cr. (Jun 2025) to -5.70 Cr., marking a decrease of 34.59 Cr..
- For Expenses, as of Sep 2025, the value is 0.42 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.40 Cr. (Jun 2025) to 0.42 Cr., marking an increase of 0.02 Cr..
- For Operating Profit, as of Sep 2025, the value is -6.12 Cr.. The value appears to be declining and may need further review. It has decreased from 28.49 Cr. (Jun 2025) to -6.12 Cr., marking a decrease of 34.61 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value appears to be declining and may need further review. It has decreased from 98.62% (Jun 2025) to 0.00%, marking a decrease of 98.62%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.05 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.05 Cr..
- For Profit before tax, as of Sep 2025, the value is -6.17 Cr.. The value appears to be declining and may need further review. It has decreased from 28.44 Cr. (Jun 2025) to -6.17 Cr., marking a decrease of 34.61 Cr..
- For Tax %, as of Sep 2025, the value is -15.24%. The value appears to be improving (decreasing) as expected. It has decreased from 14.84% (Jun 2025) to -15.24%, marking a decrease of 30.08%.
- For Net Profit, as of Sep 2025, the value is -5.22 Cr.. The value appears to be declining and may need further review. It has decreased from 24.23 Cr. (Jun 2025) to -5.22 Cr., marking a decrease of 29.45 Cr..
- For EPS in Rs, as of Sep 2025, the value is -348.00. The value appears to be declining and may need further review. It has decreased from 1,615.33 (Jun 2025) to -348.00, marking a decrease of 1,963.33.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:02 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.97 | 17.30 | 17.55 | 1.50 | 1.56 | 11.40 | 2.47 | 60.92 | 33.35 | 2.62 | 72.22 | 20.21 | -9.57 |
| Expenses | 23.64 | 23.70 | 24.47 | 7.25 | 12.52 | 3.68 | 24.71 | 2.07 | 1.89 | 1.67 | 1.80 | 1.63 | 1.65 |
| Operating Profit | -4.67 | -6.40 | -6.92 | -5.75 | -10.96 | 7.72 | -22.24 | 58.85 | 31.46 | 0.95 | 70.42 | 18.58 | -11.22 |
| OPM % | -24.62% | -36.99% | -39.43% | -383.33% | -702.56% | 67.72% | -900.40% | 96.60% | 94.33% | 36.26% | 97.51% | 91.93% | 117.24% |
| Other Income | 5.41 | 20.39 | 9.40 | 14.18 | 13.00 | -1.33 | 2.40 | 6.79 | 0.29 | 4.26 | 0.00 | 0.69 | 0.69 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 3.46 | 2.58 | 2.96 | 0.26 | 0.21 | 0.29 | 0.20 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| Profit before tax | -2.72 | 11.41 | -0.48 | 8.17 | 1.83 | 6.10 | -20.04 | 65.45 | 31.56 | 5.02 | 70.23 | 19.08 | -10.72 |
| Tax % | -1.84% | 32.52% | -179.17% | 23.87% | 24.59% | -11.64% | -1.60% | 10.94% | 11.06% | 1.79% | 17.97% | 8.23% | |
| Net Profit | -2.68 | 7.70 | 0.38 | 6.23 | 1.38 | 6.81 | -19.72 | 58.29 | 28.07 | 4.92 | 57.60 | 17.51 | -8.77 |
| EPS in Rs | -178.67 | 513.33 | 25.33 | 415.33 | 92.00 | 454.00 | -1,314.67 | 3,886.00 | 1,871.33 | 328.00 | 3,840.00 | 1,167.33 | -584.67 |
| Dividend Payout % | 0.00% | 1.95% | 39.47% | 4.82% | 10.87% | 2.20% | -0.76% | 0.51% | 1.07% | 4.57% | 0.65% | 3.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 387.31% | -95.06% | 1539.47% | -77.85% | 393.48% | -389.57% | 395.59% | -51.84% | -82.47% | 1070.73% | -69.60% |
| Change in YoY Net Profit Growth (%) | 0.00% | -482.38% | 1634.54% | -1617.32% | 471.33% | -783.05% | 785.16% | -447.43% | -30.63% | 1153.20% | -1140.33% |
Bombay Oxygen Investments Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 52% |
| 3 Years: | -15% |
| TTM: | -74% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 23% |
| 3 Years: | -15% |
| TTM: | -77% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 21% |
| 3 Years: | 28% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 2:46 pm
Balance Sheet
Last Updated: December 10, 2025, 3:59 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
| Reserves | 190.44 | 197.61 | 197.80 | 217.25 | 208.82 | 219.60 | 172.10 | 300.63 | 324.35 | 331.23 | 461.17 | 481.57 | 513.07 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 11.07 | 13.06 | 11.86 | 17.44 | 5.69 | 5.14 | 1.31 | 10.23 | 11.97 | 13.44 | 31.11 | 25.85 | 30.92 |
| Total Liabilities | 203.01 | 212.17 | 211.16 | 236.19 | 216.01 | 226.24 | 174.91 | 312.36 | 337.82 | 346.17 | 493.78 | 508.92 | 545.49 |
| Fixed Assets | 37.82 | 35.16 | 32.26 | 29.40 | 8.45 | 7.82 | 7.49 | 7.25 | 7.04 | 7.12 | 6.93 | 6.70 | 6.61 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 68.24 | 164.76 | 165.93 | 196.06 | 195.41 | 209.82 | 158.38 | 296.75 | 324.19 | 332.55 | 485.69 | 500.82 | 537.40 |
| Other Assets | 96.95 | 12.25 | 12.97 | 10.73 | 12.15 | 8.60 | 9.04 | 8.36 | 6.59 | 6.50 | 1.16 | 1.40 | 1.48 |
| Total Assets | 203.01 | 212.17 | 211.16 | 236.19 | 216.01 | 226.24 | 174.91 | 312.36 | 337.82 | 346.17 | 493.78 | 508.92 | 545.49 |
Below is a detailed analysis of the balance sheet data for Bombay Oxygen Investments Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 1.50 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.50 Cr..
- For Reserves, as of Sep 2025, the value is 513.07 Cr.. The value appears strong and on an upward trend. It has increased from 481.57 Cr. (Mar 2025) to 513.07 Cr., marking an increase of 31.50 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 30.92 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.85 Cr. (Mar 2025) to 30.92 Cr., marking an increase of 5.07 Cr..
- For Total Liabilities, as of Sep 2025, the value is 545.49 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 508.92 Cr. (Mar 2025) to 545.49 Cr., marking an increase of 36.57 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6.61 Cr.. The value appears to be declining and may need further review. It has decreased from 6.70 Cr. (Mar 2025) to 6.61 Cr., marking a decrease of 0.09 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 537.40 Cr.. The value appears strong and on an upward trend. It has increased from 500.82 Cr. (Mar 2025) to 537.40 Cr., marking an increase of 36.58 Cr..
- For Other Assets, as of Sep 2025, the value is 1.48 Cr.. The value appears strong and on an upward trend. It has increased from 1.40 Cr. (Mar 2025) to 1.48 Cr., marking an increase of 0.08 Cr..
- For Total Assets, as of Sep 2025, the value is 545.49 Cr.. The value appears strong and on an upward trend. It has increased from 508.92 Cr. (Mar 2025) to 545.49 Cr., marking an increase of 36.57 Cr..
Notably, the Reserves (513.07 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -4.67 | -6.40 | -6.92 | -5.75 | -10.96 | 7.72 | -22.24 | 58.85 | 31.46 | 0.95 | 70.42 | 18.58 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 98 | 84 | 75 | 326 | 44 | 19 | 71 | 3 | 5 | 65 | 2 | 8 |
| Inventory Days | 851 | 584 | 734 | 2 | 5 | |||||||
| Days Payable | 620 | 407 | 195 | 104 | 167 | |||||||
| Cash Conversion Cycle | 98 | 315 | 252 | 864 | -58 | -143 | 71 | 3 | 5 | 65 | 2 | 8 |
| Working Capital Days | 972 | 93 | 86 | 1,472 | -592 | 44 | 748 | 29 | 62 | 828 | 3 | 15 |
| ROCE % | -2% | 8% | -5% | 3% | -2% | 3% | -11% | 25% | 10% | 0% | 18% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Basic EPS (Rs.) | 1167.06 | 3840.06 | 328.31 | 1871.23 | 3885.80 |
| Diluted EPS (Rs.) | 1167.06 | 3840.06 | 328.31 | 1871.23 | 3885.80 |
| Cash EPS (Rs.) | 1179.98 | 3853.00 | 340.84 | 1883.90 | 3898.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 32204.87 | 30844.34 | 22182.01 | 21723.19 | 20141.89 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 32204.87 | 30844.34 | 22182.01 | 21723.19 | 20141.89 |
| Dividend / Share (Rs.) | 35.00 | 25.00 | 15.00 | 20.00 | 20.00 |
| Revenue From Operations / Share (Rs.) | 1347.54 | 4722.64 | 174.53 | 2223.11 | 4061.41 |
| PBDIT / Share (Rs.) | 1284.68 | 4694.34 | 347.17 | 2116.54 | 4376.25 |
| PBIT / Share (Rs.) | 1271.76 | 4681.40 | 334.63 | 2103.87 | 4363.26 |
| PBT / Share (Rs.) | 1271.76 | 4681.40 | 334.63 | 2103.87 | 4363.26 |
| Net Profit / Share (Rs.) | 1167.06 | 3840.06 | 328.30 | 1871.22 | 3885.80 |
| PBDIT Margin (%) | 95.33 | 99.40 | 198.91 | 95.20 | 107.75 |
| PBIT Margin (%) | 94.37 | 99.12 | 191.73 | 94.63 | 107.43 |
| PBT Margin (%) | 94.37 | 99.12 | 191.73 | 94.63 | 107.43 |
| Net Profit Margin (%) | 86.60 | 81.31 | 188.10 | 84.17 | 95.67 |
| Return on Networth / Equity (%) | 3.62 | 12.44 | 1.48 | 8.61 | 19.29 |
| Return on Capital Employeed (%) | 3.74 | 14.22 | 1.45 | 9.34 | 20.99 |
| Return On Assets (%) | 3.43 | 11.66 | 1.42 | 8.30 | 18.66 |
| Asset Turnover Ratio (%) | 0.04 | 0.16 | 0.01 | 0.10 | 0.25 |
| Current Ratio (X) | 2464.27 | 2283.32 | 1528.36 | 1414.78 | 539.42 |
| Quick Ratio (X) | 2464.27 | 2283.32 | 1528.36 | 1414.78 | 539.42 |
| Dividend Payout Ratio (NP) (%) | 2.14 | 0.39 | 6.09 | 1.06 | 0.25 |
| Dividend Payout Ratio (CP) (%) | 2.11 | 0.38 | 5.86 | 1.06 | 0.25 |
| Earning Retention Ratio (%) | 97.86 | 99.61 | 93.91 | 98.94 | 99.75 |
| Cash Earning Retention Ratio (%) | 97.89 | 99.62 | 94.14 | 98.94 | 99.75 |
| Enterprise Value (Cr.) | 331.29 | 265.65 | 154.11 | 194.17 | 163.13 |
| EV / Net Operating Revenue (X) | 16.39 | 3.75 | 58.87 | 5.82 | 2.68 |
| EV / EBITDA (X) | 17.19 | 3.77 | 29.59 | 6.12 | 2.48 |
| MarketCap / Net Operating Revenue (X) | 16.40 | 3.75 | 58.92 | 5.84 | 2.71 |
| Retention Ratios (%) | 97.85 | 99.60 | 93.90 | 98.93 | 99.74 |
| Price / BV (X) | 0.68 | 0.57 | 0.46 | 0.59 | 0.54 |
| Price / Net Operating Revenue (X) | 16.40 | 3.75 | 58.92 | 5.84 | 2.71 |
| EarningsYield | 0.05 | 0.21 | 0.03 | 0.14 | 0.35 |
After reviewing the key financial ratios for Bombay Oxygen Investments Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 100.00. This value exceeds the healthy maximum of 10. There is no change compared to the previous period (Mar 24) which recorded 100.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1,167.06. This value is within the healthy range. It has decreased from 3,840.06 (Mar 24) to 1,167.06, marking a decrease of 2,673.00.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1,167.06. This value is within the healthy range. It has decreased from 3,840.06 (Mar 24) to 1,167.06, marking a decrease of 2,673.00.
- For Cash EPS (Rs.), as of Mar 25, the value is 1,179.98. This value is within the healthy range. It has decreased from 3,853.00 (Mar 24) to 1,179.98, marking a decrease of 2,673.02.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 32,204.87. It has increased from 30,844.34 (Mar 24) to 32,204.87, marking an increase of 1,360.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 32,204.87. It has increased from 30,844.34 (Mar 24) to 32,204.87, marking an increase of 1,360.53.
- For Dividend / Share (Rs.), as of Mar 25, the value is 35.00. This value exceeds the healthy maximum of 3. It has increased from 25.00 (Mar 24) to 35.00, marking an increase of 10.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,347.54. It has decreased from 4,722.64 (Mar 24) to 1,347.54, marking a decrease of 3,375.10.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1,284.68. This value is within the healthy range. It has decreased from 4,694.34 (Mar 24) to 1,284.68, marking a decrease of 3,409.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1,271.76. This value is within the healthy range. It has decreased from 4,681.40 (Mar 24) to 1,271.76, marking a decrease of 3,409.64.
- For PBT / Share (Rs.), as of Mar 25, the value is 1,271.76. This value is within the healthy range. It has decreased from 4,681.40 (Mar 24) to 1,271.76, marking a decrease of 3,409.64.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1,167.06. This value is within the healthy range. It has decreased from 3,840.06 (Mar 24) to 1,167.06, marking a decrease of 2,673.00.
- For PBDIT Margin (%), as of Mar 25, the value is 95.33. This value is within the healthy range. It has decreased from 99.40 (Mar 24) to 95.33, marking a decrease of 4.07.
- For PBIT Margin (%), as of Mar 25, the value is 94.37. This value exceeds the healthy maximum of 20. It has decreased from 99.12 (Mar 24) to 94.37, marking a decrease of 4.75.
- For PBT Margin (%), as of Mar 25, the value is 94.37. This value is within the healthy range. It has decreased from 99.12 (Mar 24) to 94.37, marking a decrease of 4.75.
- For Net Profit Margin (%), as of Mar 25, the value is 86.60. This value exceeds the healthy maximum of 10. It has increased from 81.31 (Mar 24) to 86.60, marking an increase of 5.29.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.62. This value is below the healthy minimum of 15. It has decreased from 12.44 (Mar 24) to 3.62, marking a decrease of 8.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.74. This value is below the healthy minimum of 10. It has decreased from 14.22 (Mar 24) to 3.74, marking a decrease of 10.48.
- For Return On Assets (%), as of Mar 25, the value is 3.43. This value is below the healthy minimum of 5. It has decreased from 11.66 (Mar 24) to 3.43, marking a decrease of 8.23.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.04. It has decreased from 0.16 (Mar 24) to 0.04, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 2,464.27. This value exceeds the healthy maximum of 3. It has increased from 2,283.32 (Mar 24) to 2,464.27, marking an increase of 180.95.
- For Quick Ratio (X), as of Mar 25, the value is 2,464.27. This value exceeds the healthy maximum of 2. It has increased from 2,283.32 (Mar 24) to 2,464.27, marking an increase of 180.95.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 20. It has increased from 0.39 (Mar 24) to 2.14, marking an increase of 1.75.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.11. This value is below the healthy minimum of 20. It has increased from 0.38 (Mar 24) to 2.11, marking an increase of 1.73.
- For Earning Retention Ratio (%), as of Mar 25, the value is 97.86. This value exceeds the healthy maximum of 70. It has decreased from 99.61 (Mar 24) to 97.86, marking a decrease of 1.75.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.89. This value exceeds the healthy maximum of 70. It has decreased from 99.62 (Mar 24) to 97.89, marking a decrease of 1.73.
- For Enterprise Value (Cr.), as of Mar 25, the value is 331.29. It has increased from 265.65 (Mar 24) to 331.29, marking an increase of 65.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 16.39. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 16.39, marking an increase of 12.64.
- For EV / EBITDA (X), as of Mar 25, the value is 17.19. This value exceeds the healthy maximum of 15. It has increased from 3.77 (Mar 24) to 17.19, marking an increase of 13.42.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 16.40. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 16.40, marking an increase of 12.65.
- For Retention Ratios (%), as of Mar 25, the value is 97.85. This value exceeds the healthy maximum of 70. It has decreased from 99.60 (Mar 24) to 97.85, marking a decrease of 1.75.
- For Price / BV (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.68, marking an increase of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 16.40. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 16.40, marking an increase of 12.65.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.21 (Mar 24) to 0.05, marking a decrease of 0.16.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bombay Oxygen Investments Ltd:
- Net Profit Margin: 86.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.74% (Industry Average ROCE: 15.81%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.62% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2464.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 52.41)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 86.6%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 22/B, Mittal Tower, Mumbai Maharashtra 400021 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shyam M Ruia | Chairman |
| Ms. Hema Renganathan | Whole Time Director |
| Mr. Vikas M Jain | Non Exe.Non Ind.Director |
| Mrs. Sudha Navin Shetty | Independent Director |
| Mr. Suresh Sitaram Sigtia | Independent Director |
| Mr. Krishna Kumar Kunwar | Independent Director |
FAQ
What is the intrinsic value of Bombay Oxygen Investments Ltd?
Bombay Oxygen Investments Ltd's intrinsic value (as of 17 January 2026) is ₹3748.85 which is 81.83% lower the current market price of ₹20,637.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹310 Cr. market cap, FY2025-2026 high/low of ₹31,998/19,552, reserves of ₹513.07 Cr, and liabilities of ₹545.49 Cr.
What is the Market Cap of Bombay Oxygen Investments Ltd?
The Market Cap of Bombay Oxygen Investments Ltd is 310 Cr..
What is the current Stock Price of Bombay Oxygen Investments Ltd as on 17 January 2026?
The current stock price of Bombay Oxygen Investments Ltd as on 17 January 2026 is ₹20,637.
What is the High / Low of Bombay Oxygen Investments Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bombay Oxygen Investments Ltd stocks is ₹31,998/19,552.
What is the Stock P/E of Bombay Oxygen Investments Ltd?
The Stock P/E of Bombay Oxygen Investments Ltd is .
What is the Book Value of Bombay Oxygen Investments Ltd?
The Book Value of Bombay Oxygen Investments Ltd is 34,305.
What is the Dividend Yield of Bombay Oxygen Investments Ltd?
The Dividend Yield of Bombay Oxygen Investments Ltd is 0.17 %.
What is the ROCE of Bombay Oxygen Investments Ltd?
The ROCE of Bombay Oxygen Investments Ltd is 3.89 %.
What is the ROE of Bombay Oxygen Investments Ltd?
The ROE of Bombay Oxygen Investments Ltd is 3.62 %.
What is the Face Value of Bombay Oxygen Investments Ltd?
The Face Value of Bombay Oxygen Investments Ltd is 100.